
Sign up to save your podcasts
Or


Based on Podcast App listening data
How is innovation helping make more lungs available for lifesaving transplantation? On this episode of the ATS Breathe Easy Podcast, Alice Gallo De Moraes, MD, Mayo Clinc, speaks with Brandi Zofkie of Lung Bioengineering, about the evolving landscape of lung transplantation and the role of ex vivo lung perfusion (EVLP). They explore how this innovative technology helps evaluate donor lungs, potentially increase organ utilization, and expanding access to lung transplants. This is part 1 of a three-part mini-series. This episode was recorded on March 13, 2026.
There are new and exciting developments in the treatment of pulmonary arterial hypertension (PAH). On this episode of the ATS Breathe Easy Podcast, host Eddie Qian, MD, Vanderbilt University, sits down with Sandeep Sahay, MD, MSC, ATSF, Baylor University Medical Center, Dallas, Texas, to discuss the challenges of early diagnosis, and advances in treatment, including activin signaling inhibition with sotatercept and the potential role of new therapies. They also talk about clinical trial outcomes, balancing survival and quality of life, shared decision-making, and the future of personalized PAH treatment.
This episode is sponsored by United Therapeutics.
November is COPD Awareness Month. COPD remains a major under-recognized public health crisis, with millions affected by delayed diagnosis, stigma, and barriers to essential care. On this episode of the ATS Breathe Easy podcast, Amy Attaway, MD, Cleveland Clinic, talks with Tonya Winders, president and CEO of Global Allergy & Airways Patient Platform, about the State of COPD Report. They discuss the many causes of COPD beyond smoking, the importance of early detection and recognizing exacerbations, disparities in access to pulmonary rehabilitation, and the impact of COPD on patients and caregivers.
With the FDA approval of brensocatib, the first approved treatment specifically for non-cystic fibrosis bronchiectasis, what does this breakthrough mean for patients and clinicians? In this episode of the ATS Breathe Easy podcast, host Ugo Ezema, MD, Tulane, speaks with ATS Treasurer Gregory Tino, MD, ATSF, University of Pennsylvania, about the science behind brensocatib, findings from the ASPEN clinical trial, and promising new therapies on the horizon.
Artificial intelligence is transforming respiratory care, from detecting lung nodules to assessing cancer risk, all to help physicians make faster, more informed decisions. In this episode of the ATS Breathe Easy podcast, host Patti Tripathi speaks with James Finigan, MD, National Jewish Health, about how AI is being integrated into respiratory cancer care. He explains how AI can help with lung cancer diagnosis, the difference between assistive and augmentative AI, and what physicians need to know as these technologies become part of their clinical practice.
Career paths are rarely straight roads, instead taking unexpected twists and turns. Past ATS President M. Patricia Rivera, MD, ATSF, tells host Ugo Ezema, Tulane, how her career shifted and changed as she grew as both a professional and a person. She also provides advice for those early and mid-career professionals who are thinking about their next moves and how to navigate challenges that may come up along the way.
What does it take to go from your first ATS international conference to becoming ATS president? Raed Dweik, MD, MBA, ATSF, immediate past-president of the ATS, discusses his journey from an attendee in 1994 to becoming a part of the ATS community, ultimately serving as ATS President in 2024-2025. He discusses his legacy, how important the international conference is to building community, and more with host Ugo Ezema, MD, Tulane.
Currently, there are three treatments currently available for the treatment of pulmonary hypertension, which all work to slow the rate of loss of lung function. However, the treatment landscape is likely to evolve with the positive TETON trials demonstrating that inhaled treprostinil has independent antifibrotic properties. Expert Steven Nathan, MD, Inova, looks ahead to the future of disease-modifying therapies and what these advances mean for patients and pulmonologists, with host Ugo Ezema, MD, Tulane.
Did you know there might be a state chapter of the ATS near you? Host Erika Moseson, MD, MA, Oregon Thoracic Society, talks with Edward Kilb, MD, ATSF, South Carolina Thoracic Society, and W. Dwight Miller, MD, MS, Florida Thoracic Society, about the vital role of ATS state chapters in education, professional development, community building, and advocacy. They discuss how local chapters connect respiratory professionals with their communities, and how clinicians can turn patient experiences and scientific knowledge into meaningful advocacy.
Learn more about ATS Chapters: https://site.thoracic.org/membership/chapters
While most people are familiar with HER2 in regards to breast cancer, there are HER2 mutations in lung cancer. On this episode of the ATS Breathe Easy podcast, host Patti Tripathi explores HER2-mutant non-small cell lung cancer (NSCLC), an uncommon but increasingly treatable form of lung cancer. Oncologist Christine Lovly, MD, PhD, City of Hope, explains the rapidly evolving science behind HER2 testing and targeted therapies, while patient Nicole Field shares her experience living with stage IV HER2-mutant lung cancer.
For more resources, check out these organizations:
LUNGevity Foundation: https://www.lungevity.org/
International Cancer Advocacy Network: https://askican.org/
Rexanna’s Foundation: https://rexannasfoundation.org/
From the publisher's feed
Ranked by our users in the last 21 days

30,802 Listeners

8,752 Listeners

1,860 Listeners

322 Listeners

64 Listeners

3,645 Listeners

38 Listeners

7 Listeners

13 Listeners

892 Listeners

3,427 Listeners

1,195 Listeners

366 Listeners

58 Listeners

270 Listeners